Vigil Neuroscience, Inc.

NasdaqGS:VIGL Stock Report

Market Cap: US$168.4m

Vigil Neuroscience Balance Sheet Health

Financial Health criteria checks 6/6

Vigil Neuroscience has a total shareholder equity of $103.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $125.1M and $21.3M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$101.65m
EquityUS$103.78m
Total liabilitiesUS$21.30m
Total assetsUS$125.08m

Recent financial health updates

Recent updates

We're Keeping An Eye On Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Rate

May 30
We're Keeping An Eye On Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Rate

Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?

Feb 01
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?

Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?

Oct 14
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Jun 27
Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Mar 14
Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Nov 29
Here's Why We're Not Too Worried About Vigil Neuroscience's (NASDAQ:VIGL) Cash Burn Situation

Vigil draws bullish view at Wedbush on upcoming readout for lead asset

Sep 16

Vigil Neuroscience announces $75M PIPE financing

Aug 12

We're Hopeful That Vigil Neuroscience (NASDAQ:VIGL) Will Use Its Cash Wisely

Jul 25
We're Hopeful That Vigil Neuroscience (NASDAQ:VIGL) Will Use Its Cash Wisely

Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Invest In Growth?

Apr 10
Is Vigil Neuroscience (NASDAQ:VIGL) In A Good Position To Invest In Growth?

Financial Position Analysis

Short Term Liabilities: VIGL's short term assets ($106.5M) exceed its short term liabilities ($8.6M).

Long Term Liabilities: VIGL's short term assets ($106.5M) exceed its long term liabilities ($12.7M).


Debt to Equity History and Analysis

Debt Level: VIGL is debt free.

Reducing Debt: VIGL had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: VIGL has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: VIGL has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 29.5% each year.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.